Fact CheckerSign in

NCT04776083CompletedPhase 3

Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients

Role of Radiotherapy to the Primary Lesion in Metastatic Non-small Cell Lung Cancer Patients After First Line Systemic Therapy

Source: ClinicalTrials.gov · Last updated 19 Sept 2024

Brief summary (registry, in English)

study the effect of radiotherapy to the primary lesion after first line systemic therapy in metastatic non-small cell lung cancer patients.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
75 (actual)
First submitted
25 Feb 2021
Start date
25 Sept 2020
Primary completion date
25 Nov 2023
Lead sponsor
Menoufia University
NCT number
NCT04776083

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 75
  • From 25 Sept 2020 to the primary completion date, 25 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of prior irradiation to the lung.

Other illness

  • residual Malignant pleural or pericardial effusion at randomization time.
  • History of prior malignant tumor likely to interfere with the treatment protocol.
  • Disease progression on first line systemic therapy.

Other

  • Severe comorbidities as measured by morbidity index.

Who the study is looking for

  • Confirmed histological diagnosis of NSCLC.
  • Stage IV disease.
  • Patients with P.S ≤ 2.
  • finished at least 4 cycles of platinum-based doublet chemotherapy if patient has no diver mutation, or at least 3 months of anti-EGFR, Anti-ALK according to their driver mutation with SD, PR or CR.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medicine
Coordinator of this site? Confirm its status
Shibīn al KawmEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.